Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-21-005204
Filing Date
2021-08-05
Accepted
2021-08-05 18:33:07
Documents
1
Period of Report
2021-08-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 4285
  Complete submission text file 0001562180-21-005204.txt   5767
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Issuer) CIK: 0001822791 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6550 SOUTH MILLROCK DRIVE SUITE G50 SALT LAKE CITY UT 84121
Business Address
McLaughlin Vallerie (Reporting) CIK: 0001876030 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39834 | Film No.: 211149968